ArticleDermatology and therapy2024

A 3-Year Experience with Tildrakizumab Treatment for Patients with Plaque Psoriasis in Clinical Practice.

Martina Burlando et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.